Contineum Therapeutics, Inc. ($CTNM)
Lorrain Daniel S. โ Chief Scientific Officer
Shares
4,170
Price
$15.01
Total Value
$62,585.03
Nearby Earnings
Mar 5, 2026
EPS:Est: -0.50
Revenue:Est: $5.00M
Transaction Details
| Insider | Lorrain Daniel S. |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Mar 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Class A Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 2, 2026 |
| Shares Sold | 4,170 |
| Price per Share | $15.01 |
| Total Value | $62,585.03 |
| Shares Owned After | 151,882 |
| Derivative | No |
| Accession Number | 0001437749-26-006422 |
| Document | View SEC Filing |